ABSI · Absci Corp · Executive Compensation
$10.76
-1.35 (-11.12%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$2.08B
Shares
171.61M
Volume · Oct 30
1.93M
Avg daily vol (3M)
3.54M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Sean McClain | President, Founder and Chief Executive Officer | $3,686,615 |
| Zachariah Jonasson | Chief Financial Officer and Chief Business Officer | $2,306,795 |
| Andreas Busch | Chief Innovation Officer\ | $1,561,137 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Sean McClain | President, Founder and Chief Executive Officer | $9,786,988 |
| Zachariah Jonasson | Chief Financial Officer and Chief Business Officer | $2,832,851 |
| Andreas Busch | Chief Innovation Officer\ | $2,644,420 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Sean McClain | President, Founder and Chief Executive Officer | $3,097,371 |
| Zachariah Jonasson | Chief Financial Officer and Chief Business Officer | $2,204,673 |
| Andreas Busch | Chief Innovation Officer\ | $2,151,303 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Andreas Busch | Chief Innovation Officer\ | $4,732,732 |
| Sean McClain | President, Founder and Chief Executive Officer | $4,013,426 |
| Sarah Korman | Chief Legal Officer | $3,237,403 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Nikhil Goel | former Chief Business Officer and current Chief Strategy Officer | $5,262,302 |
| Sean McClain | President, Founder and Chief Executive Officer | $3,741,313 |
| Sarah Korman | Chief Legal Officer | $2,586,922 |
| Matthew Weinstock | Chief Technology Officer | $2,324,195 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Sean McClain | President, Founder and Chief Executive Officer | $1,180,884 |
| Matthew Weinstock | Chief Technology Officer | $453,459 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Andreas Busch, Ph.D. | Chief Innovation Officer | Retired | 2026-03-06 |
| Ransi Somaratne | Chief Medical Officer | Appointed | 2026-03-06 |
| Andreas Busch | Chief Innovation Officer | Retired | 2026-03-06 |
| Mary Szela | Class III director | Appointed | 2025-07-08 |
| Amrit Nagpal | Board of Directors | Resigned | 2025-04-28 |
| Professor Sir Menelas Pangalos | Class II director of the Company | Appointed | 2023-12-07 |
| Zachariah Jonasson, Ph.D. | Board of Directors | Resigned | 2023-08-14 |
| Zachariah Jonasson, Ph.D. | Chief Business Officer | Appointed | 2023-08-14 |
| Zachariah Jonasson, Ph.D. | Chief Financial Officer | Appointed | 2023-08-14 |
| Frans van Houten | Class I director | Appointed | 2023-06-06 |
| Dan Rabinovitsj | Class II director | Appointed | 2022-11-02 |
| Andreas Busch, Ph.D. | Chief Innovation Officer | Appointed | 2022-10-04 |
| Andreas Busch, Ph.D. | Board of Directors | Resigned | 2022-10-04 |
| Nikhil Goel | Chief Strategy Officer | Terminated | 2022-09-20 |
| Eli Casdin | Board of Directors | Resigned | 2022-07-14 |
Leadership
- Sean McClain CEO, Board Member
- Zachariah Jonasson CFO
- Zachariah Jonasson, Ph.D. CFO
- Matthew Weinstock CTO
- Andreas Busch, Ph.D. CIO
- Sarah Korman General Counsel
- Dan Rabinovitsj Board Member
- Daniel Rabinovitsj Board Member
- Dr. Andreas Busch Board Member
- Dr. Joseph Sirosh Board Member
- Mary Szela Board Member
- Prof Sir Menelas Pangalos Board Member
- Professor Sir Menelas Pangalos Board Member
Key facts
CIK
1672688
CUSIP
00091E109
13F (30d)
38 filings
38 filers
Visit website
Investor relations